Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon F Keele

Showing results (121-130 of 230) with videos related to

Pageof 23
Sort By:
Mucosal Immunology|June 17, 2018
Intestinal damage precedes mucosal immune dysfunction in SIV infectionTiffany Hensley-McBain, Alicia R Berard, Jennifer A Manuzak, et al.
Science (New York, N.Y.)|September 7, 2019
Blocking α<sub>4</sub>β<sub>7</sub> integrin binding to SIV does not improve virologic controlNami Iwamoto, Rosemarie D Mason, Kaimei Song, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Journal of Virology|May 12, 2007
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzeesJun Takehisa, Matthias H Kraus, Julie M Decker, et al.
Journal of Virology|October 11, 2019
<i>In Vivo</i> Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency VirusesSirish Khanal, Christine M Fennessey, Sean P O'Brien, et al.
Nature Communications|February 14, 2024
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kim, Deepanwita Bose, Mariluz Araínga, et al.
Cell Host & Microbe|May 14, 2016
HIV-1 Vpu Mediates HLA-C DownregulationRichard Apps, Gregory Q Del Prete, Pramita Chatterjee, et al.
Science Advances|June 1, 2019
Defining early SIV replication and dissemination dynamics following vaginal transmissionClaire Deleage, Taina T Immonen, Christine M Fennessey, et al.
Science (New York, N.Y.)|September 7, 2019
Lack of therapeutic efficacy of an antibody to α<sub>4</sub>β<sub>7</sub> in SIVmac251-infected rhesus macaquesPeter Abbink, Noe B Mercado, Joseph P Nkolola, et al.
Science Translational Medicine|August 11, 2017
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infectionMatthew S Parsons, Sarah B Lloyd, Wen Shi Lee, et al.
Pageof 23

Showing results (121-130 of 230) with videos related to

Sort By:
Pageof 23
Mucosal Immunology|June 17, 2018
Intestinal damage precedes mucosal immune dysfunction in SIV infectionTiffany Hensley-McBain, Alicia R Berard, Jennifer A Manuzak, et al.
Science (New York, N.Y.)|September 7, 2019
Blocking α<sub>4</sub>β<sub>7</sub> integrin binding to SIV does not improve virologic controlNami Iwamoto, Rosemarie D Mason, Kaimei Song, et al.
Journal of Virology|February 6, 2009
In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadthXiaoying Shen, Robert J Parks, David C Montefiori, et al.
Journal of Virology|May 12, 2007
Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzeesJun Takehisa, Matthias H Kraus, Julie M Decker, et al.
Journal of Virology|October 11, 2019
<i>In Vivo</i> Validation of the Viral Barcoding of Simian Immunodeficiency Virus SIVmac239 and the Development of New Barcoded SIV and Subtype B and C Simian-Human Immunodeficiency VirusesSirish Khanal, Christine M Fennessey, Sean P O'Brien, et al.
Nature Communications|February 14, 2024
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kim, Deepanwita Bose, Mariluz Araínga, et al.
Cell Host & Microbe|May 14, 2016
HIV-1 Vpu Mediates HLA-C DownregulationRichard Apps, Gregory Q Del Prete, Pramita Chatterjee, et al.
Science Advances|June 1, 2019
Defining early SIV replication and dissemination dynamics following vaginal transmissionClaire Deleage, Taina T Immonen, Christine M Fennessey, et al.
Science (New York, N.Y.)|September 7, 2019
Lack of therapeutic efficacy of an antibody to α<sub>4</sub>β<sub>7</sub> in SIVmac251-infected rhesus macaquesPeter Abbink, Noe B Mercado, Joseph P Nkolola, et al.
Science Translational Medicine|August 11, 2017
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infectionMatthew S Parsons, Sarah B Lloyd, Wen Shi Lee, et al.
Pageof 23